Skip to content
Menu
CBD MEDICAL NETWORK
  • Das CBD Medical Network mit Infothek
  • Das Netzwerk („in incrementum“)
  • Kontakt
CBD MEDICAL NETWORK

Ideal drug to treat non-motor Parkinson’s disease symptoms?

Posted on 20. Februar 2020

Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms? (Feb 2019)

PubMed

In the present text, we review the clinical studies of cannabinoids in PD and the preclinical and clinical studies specifically on CBD.

We found four randomized controlled trials (RCTs) involving the administration of agonists/antagonists of the cannabinoid 1 receptor, showing that these compounds were well tolerated, but only one study found positive results (reductions on levodopa-induced dyskinesia).

We found seven preclinical models of PD using CBD, with six studies showing a neuroprotective effect of CBD.

We found three trials involving CBD and PD: an open-label study, a case series, and an RCT. CBD was well tolerated, and all three studies reported significant therapeutic effects in non-motor symptoms (psychosis, rapid eye movement sleep behaviour disorder, daily activities, and stigma). However, sample sizes were small and CBD treatment was short (up to 6 weeks).

Large-scale RCTs are needed to try to replicate these results and to assess the long-term safety of CBD.

Zum Artikel.

Unsere Info-Mails

Aktuelle Beiträge in der Infothek

  • TRPV1 schützt Neuronen bei Multipler Sklerose
  • CBD im Einsatz gegen CoVid.
  • Gedanken zu den ersten Cannabinoiden bzw. den Säure-Vorstufen
  • Das antimikrobielle Potenzial von Cannabidiol
  • Cannabigerol (CBG) aus pharmakologischer Sicht

Nach Stichworten suchen

Impressum & Datenschutz

Impressum & Datenschutz

Rechtliches

Impressum & Datenschutz

©2023 CBD MEDICAL NETWORK | Powered by WordPress and Superb Themes!